Stroke pathophysiology: management challenges and new treatment advances

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of physiology and biochemistry

• Publication date

  2007-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF03165789PMID 18309782
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in stroke therapy

  2011cited by this paper
• Hazards of therapy for excessive hypertension in acute stroke.

  2009cited by this paper
• MINOCYCLINE TREATMENT IN ACUTE STROKE : AN OPEN-LABEL, EVALUATOR-BLINDED STUDY. Authors' reply

  2008cited by this paper
• Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation.

  2007cited by this paper
• Albumin therapy in acute stroke patients

  2007cited by this paper
• Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study.

  2007cited by this paper
• NXY-059 for the treatment of acute ischemic stroke.

  2007cited by this paper
• Minocycline and cytoprotection: shedding new light on a shadowy controversy.

  2007cited by this paper
• Prior Statin Use May Be Associated With Improved Stroke Outcome After Tissue Plasminogen Activator

  2007cited by this paper
• Reactive Oxygen Species and p38 Mitogen-Activated Protein Kinase Activate Bax to Induce Mitochondrial Cytochrome c Release and Apoptosis in Response to Malonate

  2007cited by this paper
• Minocycline treatment in acute stroke

  2007cited by this paper
• Safety and tolerability of arundic acid in acute ischemic stroke.

  2006cited by this paper
• The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—I: Physiological Responses and Safety Results

  2006cited by this paper
• Neuroprotection against focal ischemic brain injury by the peroxisome proliferator‐activated receptor‐γ agonist rosiglitazone

  2006cited by this paper
• NXY-059 for acute ischemic stroke.

  2006cited by this paper
• Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia.

  2006cited by this paper
• Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the

  2006cited by this paper
• Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the

  2006cited by this paper
• The ALIAS Pilot Trial: A Dose-Escalation and Safety Study of Albumin Therapy for Acute Ischemic Stroke—II: Neurologic Outcome and Efficacy Analysis

  2006cited by this paper
• EFNS guideline on the treatment of cerebral venous and sinus thrombosis

  2006cited by this paper
• Moderate hypothermia prevents neural cell apoptosis following spinal cord ischemia in rabbits

  2005cited by this paper
• Combined IV and intra-arterial thrombolysis for acute ischemic stroke

  2005cited by this paper
• Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.

  2005cited by this paper
• Multitargeted Effects of Statin-Enhanced Thrombolytic Therapy for Stroke With Recombinant Human Tissue-Type Plasminogen Activator in the Rat

  2005cited by this paper
• Safety and Efficacy of Mechanical Embolectomy in Acute Ischemic Stroke: Results of the MERCI Trial

  2005cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke

  2005cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke

  2005cited by this paper
• Cooling for Acute Ischemic Brain Damage (COOL AID)

  2004cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.

  2004cited by this paper
• Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

  2004cited by this paper
• p53: Twenty five years understanding the mechanism of genome protection

  2004cited by this paper
• Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins

  2004cited by this paper
• Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial.

  2004cited by this paper
• Prehospital Neuroprotective Therapy for Acute Stroke: Results of the Field Administration of Stroke Therapy–Magnesium (FAST–MAG) Pilot Trial

  2004cited by this paper
• Hyperglycemia in Acute Stroke

  2004cited by this paper
• Rising statin use and effect on ischemic stroke outcome

  2004cited by this paper
• Neuroprotective effects of a dual L/N-type Ca(2+) channel blocker cilnidipine in the rat focal brain ischemia model.

  2004cited by this paper
• Carotid artery dissection

  2004cited by this paper
• Clinical trial of a novel surface cooling system for fever control in neurocritical care patients*

  2004cited by this paper
• Clinically Approved Heterocyclics Act on a Mitochondrial Target and Reduce Stroke-induced Pathology

  2004cited by this paper
• Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.

  2004cited by this paper
• Acute Ischemic Stroke Treatment: An Emergency B. Therapy

  2003cited by this paper
• Effects of Hypothermia on Energy Metabolism in Mammalian Central Nervous System

  2003cited by this paper
• The ACCESS Study: Evaluation of Acute Candesartan Cilexetil Therapy in Stroke Survivors

  2003cited by this paper
• Detrimental effect of blood pressure reduction in the first 24 hours of acute stroke onset

  2003cited by this paper
• Reactive oxygen species induce swelling and cytochrome c release but not transmembrane depolarization in isolated rat brain mitochondria

  2003cited by this paper
• Mitochondrial control of neuron death and its role in neurodegenerative disorders

  2003cited by this paper
• Acute Ischemic Stroke Treatment: An Emergency B. Therapy

  2003cited by this paper
• Role and regulation of p53 in depolarization-induced neuronal death.

  2003cited by this paper
• Association between course of blood pressure within the first 24 hours and functional recovery after acute ischemic stroke.

  2003cited by this paper
• Excitatory amino acid antagonists for acute stroke.

  2003cited by this paper
• Emergent Use of Anticoagulation for Treatment of Patients With Ischemic Stroke

  2002cited by this paper
• Neuroprotection : The 2002 Thomas Willis Lecture Adventures in the Pathophysiology of Brain Ischemia : Penumbra , Gene Expression

  2002cited by this paper
• Anticoagulants and antiplatelet agents in acute ischemic stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)

  2002cited by this paper
• Markers of Increased Risk of Intracerebral Hemorrhage After Intravenous Recombinant Tissue Plasminogen Activator Therapy for Acute Ischemic Stroke in Clinical Practice: The Multicenter rt-PA Acute Stroke Survey

  2002cited by this paper
• Anticoagulants and Antiplatelet Agents in Acute Ischemic Stroke: Report of the Joint Stroke Guideline Development Committee of the American Academy of Neurology and the American Stroke Association (a Division of the American Heart Association)

  2002cited by this paper
• Analysis of the Safety and Efficacy of Intra-Arterial Thrombolytic Therapy in Ischemic Stroke

  2002cited by this paper
• Effect of Paracetamol (Acetaminophen) on Body Temperature in Acute Ischemic Stroke: A Double-Blind, Randomized Phase II Clinical Trial

  2001cited by this paper
• Tirilazad for acute ischaemic stroke.

  2001cited by this paper
• Risk Factors for Severe Hemorrhagic Transformation in Ischemic Stroke Patients Treated With Recombinant Tissue Plasminogen Activator: A Secondary Analysis of the European-Australasian Acute Stroke Study (ECASS II)

  2001cited by this paper
• Antithrombotic and thrombolytic therapy for ischemic stroke.

  2001cited by this paper
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

  2000cited by this paper
• Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study.

  2000cited by this paper
• Phase II Clinical Trial of Sipatrigine (619C89) by Continuous Infusion in Acute Stroke

  2000cited by this paper
• Stroke precipitated by moderate blood pressure reduction.

  2000cited by this paper
• Randomized, placebo-controlled trial of anticoagulant treatment with low-molecular-weight heparin for cerebral sinus thrombosis.

  1999cited by this paper
• The clomethiazole acute stroke study (CLASS): efficacy results in 545 patients classified as total anterior circulation syndrome (TACS).

  1999cited by this paper
• Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey

  1999cited by this paper
• Early cellular events in the penumbra of human spontaneous intracerebral hemorrhage.

  1999cited by this paper
• Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.

  1999cited by this paper
• Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia.

  1998cited by this paper
• Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

  1998cited by this paper
• Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group.

  1998cited by this paper
• Early intravenous thrombolysis for acute ischemic stroke in a community-based approach.

  1998cited by this paper
• CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group.

  1997cited by this paper
• Effects of hypothermia on the neuronal activity, [Ca2+]i accumulation and ATP levels during oxygen and/or glucose deprivation in hippocampal slices of guinea pigs.

  1997cited by this paper
• The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group.

  1997cited by this paper
• Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Lubeluzole International Study Group.

  1996cited by this paper
• Treatment of Post-Stroke Hypertension

  1996cited by this paper
• Effects of hypothermia on the rate of excitatory amino acid release after ischemic depolarization.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Acute hypertension after stroke

  1993cited by this paper
• Should hypertension be treated after acute stroke? A randomized controlled trial using single photon emission computed tomography.

  1993cited by this paper
• Effect of Antihypertensive Treatment on Focal Cerebral Infarction

  1992cited by this paper
• Heparin treatment in sinus venous thrombosis.

  1991cited by this paper
• Special report from the National Institute of Neurological Disorders and Stroke. Classification of cerebrovascular diseases III.

  1990cited by this paper
• The role of glutamate neurotoxicity in hypoxic-ischemic neuronal death.

  1990cited by this paper
• Management of hypertension in patients with acute stroke.

  1986cited by this paper
• Neurological outcome in cold water drowning.

  1981cited by this paper
• Neurological Outcome in Cold Water Drowning

  1980cited by this paper
• EFFECT OF HYPOTHERMIA UPON ORGANIC PHOSPHATES, GLYCOLYTIC METABOLITES, CITRIC ACID CYCLE INTERMEDIATES AND ASSOCIATED AMINO ACIDS IN RAT CEREBRAL CORTEX

  1975cited by this paper
• Section Editors: Extracranial Arterial Dissection Anticoagulation Is the Treatment of Choice: for Controversies in Stroke

  year unknowncited by this paper

• Electroacupuncture pretreatment enhances the calcium efflux activity of Na+/Ca2+ exchanger to attenuate cerebral injury by PI3K/Akt-mediated NCX1 upregulation after focal cerebral ischaemia

  2024cites this paper
• Obesity and Stroke: Does the Paradox Apply for Stroke?

  2021cites this paper
• Endovascular Stem Cell Therapy Post Stroke Rescues Neurons from Endoplasmic Reticulum Stress-Induced Apoptosis by Modulating Brain-Derived Neurotrophic Factor/Tropomyosin Receptor Kinase B Signaling.

  2021cites this paper
• Atlas interactivo de neuroimágenes y correlación clínico-imagenológica en ataque cerebrovascular agudo: recurso digital educativo

  2017cites this paper
• Advances in Personalized Nanotherapeutics

  2017cites this paper
• CNS Drug Delivery for Diseases Eradication: An Overview

  2017cites this paper
• Diallyl trisufide protects against oxygen glucose deprivation -induced apoptosis by scavenging free radicals via the PI3K/Akt -mediated Nrf2/HO-1 signaling pathway in B35 neural cells.

  2015cites this paper
• Assessment of human kinematic performance with non-contact measurements for tele-rehabilitation

  2015cites this paper
• Effect of ligustrazine on levels of amino acid neurotransmitters in rat striatum after cerebral ischemia-reperfusion injury

  2014cites this paper
• Minocycline mediated mitochondrial cytoprotection: premises for therapy of cerebrovascular and neurodegenerative diseases.

  2013cites this paper
• Regulación de la expresión del receptor NMDA por el resveratrol en isquemia cerebral in vivo

  2013influential citation
• Progesterone as a neuroprotectant in stroke

  2013cites this paper
• Trends in Age-Standardized and Age-Specific Cerebrovascular Mortality in Germany between 1980 and 2009

  2012cites this paper
• Minocycline Mediated Mitochondrial Cytoprotection: Premises for Therapy of Cerebrovascular and Neurodegenerative Diseases

  2012cites this paper
• [The role played by Toll-like receptors in cerebral infarction processes].

  2011cites this paper
• Peripheral Administration of Human Adrenomedullin and Its Binding Protein Attenuates Stroke-Induced Apoptosis and Brain Injury in Rats

  2011cites this paper
• Risk of Stroke in Older Women Treated for Early Invasive Breast Cancer, Tamoxifen vs. Aromatase Inhibitors: A Population based Retrospective Cohort Study

  2010cites this paper
• [Inflammatory response during ischaemic processes: adhesion molecules and immunomodulation].

  2010cites this paper
• Farmacología de la neuroprotección en el ictus isquémico agudo

  2008cites this paper
• [Pharmacology of neuroprotection in acute ischemic stroke].

  2008cites this paper
• Knockdown of NEAT1 prevents lipid droplet accumulation in microglia after ischemic stroke via autophagy

  year unknowncites this paper